Urgent need for forward-looking EU regulation to boost innovation for animal health and welfare.
IFAH-Europe calls on EU regulators to ensure that forthcoming legislation on veterinary medicine is fit for purpose and stands test of time.
The European animal health industry today called on the European Union to ensure that the forthcoming legislation on animal medicines and medicated feed will foster innovation and increase the availability of veterinary medicines to protect the health and welfare of all animals across Europe.
At the close of the Summit in Ise-Shima (Japan), G7 leaders issued a declaration outlining their current thinking on antimicrobial resistance. In advance of this Summit meeting, IFAH-Europe had called on the G7 Summit leaders to consider a holistic One Health approach in dealing with antimicrobial resistance (AMR) and infectious diseases, as a reminder to policy-makers that AMR is not only a topic of concern for human and public health, but also for animal health.
Ahead of the G7 Summit on 26-27 May in Ise-Shima, Japan and following on from the meeting in April (23-24) of the agricultural ministers of the G7, Europe’s animal health industry is urging the leaders of the G7 summit to consider a holistic One Health approach in dealing with antimicrobial resistance (AMR) and infectious diseases. In so doing, the animal health sector in Europe seeks to remind policy-makers that AMR concerns not only human and public health, but also animal health.
The final report of the O’Neill Review on Antimicrobial Resistance (AMR), released today, overall makes some good recommendations in terms of encouraging innovation for the quick development of new diagnostics, promoting the use of vaccines and alternatives to antibiotics, improving surveillance of AMR and antibiotic consumption in both people and animals, as well as endorsing better incentives to encourage investment for new medicines and improving existing ones, as well as the setting up of a Global Innovation Fund.